Problem 1 - Brenner and Stevens’ Pharmacology

Question

Which of the following correctly describes monteleukast? (A) blocks receptors for leukotrienes \(\mathrm{C}_4, \mathrm{D}_4\), and \(\mathrm{E}_4\) (B) inhibits cytochrome P450 enzymes (C) is administered twice daily (D) inhibits formation of leukutriene \(\mathrm{A}_4\) (E) is excreted unchanged in the urine

Step-by-Step Solution

Answer

The correct description is (A) blocks receptors for leukotrienes C4, D4, and E4.

Step 1: Understanding Monteleukast's Function

Monteleukast is a medication primarily used in the management of asthma and allergic rhinitis. Its primary function is to block leukotriene receptors.

Step 2: Identifying the Correct Receptors

Monteleukast specifically blocks the leukotriene receptors known as LTC4, LTD4, and LTE4. This action prevents leukotrienes from binding and causing inflammation associated with asthma.

Step 3: Reviewing Answer Choices

Let's review the options given in the question: - (A) Blocks receptors for leukotrienes C4, D4, and E4: This describes exactly what monteleukast does. - (B) Inhibits cytochrome P450 enzymes: This is not a primary function of monteleukast. - (C) Is administered twice daily: Monteleukast is typically administered once daily. - (D) Inhibits formation of leukotriene A4: This describes another class of drugs, not monteleukast specifically. - (E) Is excreted unchanged in the urine: Monteleukast is primarily metabolized by the liver.

Step 4: Selecting the Correct Answer

Given the reviews of the answer choices, the correct description of monteleukast is option (A): 'blocks receptors for leukotrienes C4, D4, and E4'.

Key Concepts

Asthma management

Asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways, making breathing difficult. The management of asthma involves a combination of medications and lifestyle changes to control symptoms and prevent flare-ups.
Monteleukast is a key medication in asthma management. It helps to prevent asthma symptoms by blocking substances in the body called leukotrienes.
Leukotrienes are chemicals your body releases when you breathe in allergens, causing inflammation and swelling in the airways. By blocking these chemicals, monteleukast helps to reduce inflammation and asthma symptoms.
Effective asthma management often includes:

• Avoiding asthma triggers like smoke, dust mites, and pollen.
• Using medications like monteleukast as a preventive measure.
• Monitoring symptoms regularly and creating an action plan with a healthcare provider.

Monteleukast is often prescribed alongside inhalers and other medications to enhance overall asthma control.

Leukotriene receptor antagonist

Monteleukast belongs to a class of drugs known as leukotriene receptor antagonists. These medications work by targeting specific receptors in the body that respond to leukotrienes, such as LTC4, LTD4, and LTE4.
Leukotrienes play a significant role in the body's inflammatory response, particularly in asthma and allergic rhinitis. By preventing leukotrienes from binding to their receptors, monteleukast effectively reduces inflammation and constriction of the airways.
This mechanism of action makes leukotriene receptor antagonists a vital component in the treatment of conditions where inflammation is a key issue. They are particularly useful for patients who may not respond well to inhaled corticosteroids or need additional symptom control.
Monteleukast is usually taken orally, making it a convenient option for long-term management of asthma and allergic rhinitis.

Allergic rhinitis treatment

Allergic rhinitis, commonly known as hay fever, is an allergic reaction that causes sneezing, congestion, and a runny nose. It can greatly affect your quality of life, especially during allergy season.
Monteleukast is used as a treatment for allergic rhinitis due to its ability to block leukotriene receptors. This action helps to relieve symptoms by reducing nasal swelling and congestion.
Benefits of using monteleukast for allergic rhinitis include:

• Fewer side effects compared to some other allergy medications.
• Once-daily dosing, making it easy to incorporate into a daily routine.
• Effective for both seasonal and perennial allergic rhinitis.

When used as part of a treatment plan, monteleukast can help improve the quality of life for individuals suffering from allergic rhinitis.

Pharmacology study

Pharmacology is the study of how drugs interact with biological systems. It helps to understand how medications work within the body to provide therapeutic effects.
Studying pharmacology involves understanding the mechanism of action, metabolism, and effects of drugs such as monteleukast. For monteleukast, key points in pharmacology include:

• Action: It blocks leukotriene receptors, reducing inflammation.
• Metabolism: Primarily metabolized in the liver.
• Excretion: Metabolites are excreted in the urine and feces.

Pharmacology also covers potential interactions with other drugs and identifying patients who would benefit the most from a particular treatment. For example, monteleukast does not significantly interact with cytochrome P450 enzymes, making it less likely to interfere with the metabolism of other drugs.
Understanding these aspects helps healthcare providers tailor therapy to individual patient needs, optimizing treatment outcomes.